Income statement
GBP
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 259M | 94M | 170M | 154M | 146M |
| Gross Profit | 232M | 94M | 151M | 142M | 137M |
| Operating Income | 202M | 47M | 84M | 70M | 237M |
| EBITDA | 207M | 0 | 0 | 98M | 126M |
| Net Income | 119M | 41M | 27M | 56M | 140M |
| EPS (Diluted) | — | — | — | — | — |
Real Estate
Live Price
Offline$1.31
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars · May 29, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Primary Health Properties PLC (PHPRF) is a Real Estate stock with a market cap of $1.26B and listed on OTC. The stock last traded around $1.31 and up 0.0% across the available one-year price window (May 29, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of +176.1%, EPS growth of +112.9%, a dividend yield of 7.6%. What stands out right now is revenue +176.1%, EPS +112.9%, free cash flow -100.0% with operating margin 78.4% and ROIC 3.3%. The dividend matters to the case here, with a current yield around 7.6%. Valuation sits in the middle of the pack at P/E 20.6 and price/sales 4.9. Stock Foundry combines PHPRF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PHPRF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PHPRF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PHPRF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$145.6M
-5.5% YoY
FY Net Income
$140.1M
+148.8% YoY
Free Cash Flow
$140.4M
+19.4% YoY
Revenue Growth
+176.1%
EPS Growth
+112.9%
Gross Margin
59.0%
Net Margin
45.9%
Income statement
GBP
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 259M | 94M | 170M | 154M | 146M |
| Gross Profit | 232M | 94M | 151M | 142M | 137M |
| Operating Income | 202M | 47M | 84M | 70M | 237M |
| EBITDA | 207M | 0 | 0 | 98M | 126M |
| Net Income | 119M | 41M | 27M | 56M | 140M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
GBP
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 20M | 4M | 3M | 29M | 33M |
| Total Assets | 6.0B | 2.8B | 2.8B | 2.9B | 2.9B |
| Total Liabilities | 3.5B | 1.4B | 1.4B | 1.4B | 1.4B |
| Shareholder Equity | 2.6B | 1.4B | 1.4B | 1.5B | 1.5B |
| Total Debt | 3.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Net Debt | 3.3B | -4M | 1.3B | 1.3B | 1.2B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
140M
+19.4% YoY
Capital Expenditures
0
Free Cash Flow
140M
+19.4% YoY
Key ratios
Gross Margin
59.0%
Operating Margin
78.4%
Net Margin
45.9%
ROE
6.0%
Debt / Equity
1.29x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.